Brown Gibbons Lang & Company, a leading middle market investment bank, announced today that it has formalized a dedicated practice focused on the healthcare industry. To lead this effort, the firm has appointed a veteran investment banker, who will build upon BGL’s historical activity in healthcare. The addition of a senior healthcare banker and a dedicated focus will enable BGL to provide informed, experienced healthcare advisory and capital markets services to clients in the U.S. and globally through its Global M&A partnership.
John C. Riddle joins BGL as a managing director and principal, and head of the firm’s healthcare practice. Riddle is a seasoned investment banker with twenty years of investment banking and capital markets experience, advising healthcare clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic advisory assignments.
“Brown Gibbons Lang & Company focuses on providing unbiased, creative, value-added advice and services to clients across a broad spectrum of industries where we have deep experience and expertise,” said Michael Gibbons, senior managing director of BGL. “Now is the right time for us to expand our effort in healthcare. The healthcare industry is undergoing significant regulatory and secular changes, which we believe will drive significant strategic transaction volume, increased capital requirements, and expanded investor appetite.”
Current industry trends, including new business models emerging from the recent health reform, strategic alignment and realignment among the provider market, ongoing technology innovation and consolidation in life sciences, and a shifting IT and outsourced services market, will drive M&A and capital requirements in healthcare. BGL’s healthcare practice will maintain a primary focus in provider services, diagnostics, managed care services, health and wellness, pharmaceutical services, and niche outsourcing strategies.
“John brings extensive industry expertise, contacts, and perspective in healthcare,” said John Tilson, managing director. “Importantly, too, John is a thoughtful, competitive, and creative banker who is a good fit with our culture. He shares our philosophy of providing senior level attention to each engagement and a focus on achieving exceptional results for our clients.”
Riddle brings a wealth of experience and a strong track record of leading and growing successful healthcare practices. Prior to joining BGL, Riddle was a managing director in the healthcare group and led the healthcare services effort at GCA Savvian Advisors. Before that, Riddle established and led the healthcare practice at Dresner Partners, with a broad focus in healthcare services, outsourcing, and diagnostics. He also was the Director of Corporate Development at Teliconics, Inc., a medical device company, in addition to working in the leveraged finance group of Continental Bank, prior to its acquisition by Bank of America.
“Healthcare is a very large and diverse industry, comprised primarily of middle market companies with increasingly sophisticated advisory and capital markets requirements,” said Riddle. “BGL’s middle market focus and global reach, along with its experienced team and culture of excellence, provides a strong platform from which to expand our healthcare business.”
Brown Gibbons Lang & Company is a leading independent investment bank serving middle market companies and their owners throughout the United States and internationally. BGL’s professionals are active across a number of industry sectors, delivering high-quality mergers & acquisitions advisory services, debt & equity placements, valuations and fairness opinions, and financial restructurings. BGL is the lead U.S. shareholder in Global M&A, the world’s leading partnership of top-tier independent financial advisory firms focusing on mid-market cross-border transactions. For more information, please visit www.bglco.com.
Global M&A is the world’s leading partnership of top-tier independent financial advisory firms focusing on mid-market cross-border transactions with values between $25 and $500 million. The Global M&A partnership consists of 40 members in financial centers spanning the globe. Members have completed more than 1,500 transactions with an aggregate deal value exceeding $20 billion since 2000. Global M&A was named 2005 Investment Bank of the Year by The M&A Advisor, a leading publication dedicated to middle market mergers.